Private company
Arch Therapeutics, Inc.
Last updated Oct 16, 2026.
Overview
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2023
Where the money goes
Where each dollar of revenue went, fiscal 2023
- Cost of revenue1¢$78.2K
- Research and development8¢$670.9K
- Selling, general and admin53¢$4.4M
- Interest38¢$3.1M
Out of $75.7K in revenue.3 The company lost money this year.
Financial statements
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenue | $04 | $05 | $06 | $07 | $11.6K8 | $15.7K3 | $75.7K3 |
| Cost of revenue | $26.3K8 | $51.5K3 | $78.2K3 | ||||
| Research and development | $2.1M4 | $2.9M5 | $2.4M6 | $1.6M7 | $1.4M8 | $1.2M3 | $670.9K3 |
| Selling, general and admin | $3.7M7 | $5.0M8 | $4.5M3 | $4.4M3 | |||
| Operating income | -$7.3M4 | -$7.4M5 | -$6.4M6 | -$5.4M7 | -$6.4M8 | -$5.7M3 | -$5.0M3 |
| Interest | $52.4K4 | $04 | $18.5K7 | $150.5K8 | $567.0K3 | $3.1M3 | |
| Net income | -$7.8M4 | -$4.8M5 | -$4.5M6 | -$4.7M7 | -$6.2M8 | -$5.3M3 | -$7.0M3 |
| Earnings per share | -$0.027 | -$0.038 | -$4.403 | -$2.273 | |||
| Earnings per share (diluted) | -$0.027 | -$0.037 |
| Fiscal year | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Cash | $6.0M4 | $4.7M4 | $2.2M7 | $959.3K7 | $2.3M7 | ||
| Current assets | $6.1M4 | $4.8M5 | $2.9M6 | $2.1M7 | $3.7M8 | $2.6M3 | $2.0M3 |
| Total assets | $6.1M4 | $4.8M5 | $2.9M6 | $2.2M7 | $3.7M8 | $2.6M3 | $2.0M3 |
| Current liabilities | $433.5K4 | $288.4K5 | $713.8K6 | $628.5K7 | $1.7M8 | $3.3M3 | $9.5M3 |
| Long-term debt | $06 | $138.9K7 | $07 | ||||
| Total liabilities | $3.9M4 | $3.5M5 | $3.7M6 | $3.7M7 | $4.7M8 | $6.8M3 | $9.5M3 |
| Shareholders’ equity | $2.2M5 | $1.4M6 | -$807.3K7 | -$1.5M8 | -$1.0M3 | -$4.2M3 | -$7.5M3 |
| Shares outstanding | 153.9M shares11 | 164.4M shares4 | 187.9M shares5 | 193.0M shares6 | 237.2M shares12 | 249.9M shares8 | 4.7M shares3 |
Former names
- ALMAH,INCJan 5, 2012 to May 24, 20132
Recent filings
- May 23, 20258-K
- Feb 7, 20258-K
- Jan 23, 20258-K
- Nov 7, 20248-K
- Nov 4, 20248-K
- Sep 26, 20248-K
- Sep 19, 20248-K
- Sep 13, 20248-K
- Aug 30, 20248-K
- Aug 20, 20248-K
- Aug 19, 202410-Q
- Aug 16, 20248-K
- Aug 16, 20248-K
- Aug 2, 20248-K
- Jul 22, 20248-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12